Adaptiiv Medical Technologies Inc. adds Travis Gay to its Board of Directors
As Adaptiiv Medical Technologies Inc. (Adaptiiv) increases traction in the market and prepares to capitalize on strategic opportunities, it has become necessary to add specific commercial experience to its Board of Directors. As such, Adaptiiv is pleased to announce the appointment of Mr. Travis Gay to its Board, effective immediately. Travis is an industry veteran with vast experience in scaling companies in the healthcare industry.
In his current position as Chief Commercial Officer and co-founder at Palette Life Sciences, Travis leverages his vision, passion, and leadership when transforming innovations in medical technology into commercially successful organizations. He has led all developmental components of an organization, from raising capital and acquiring valuable assets to executing the sell side.
For the past 25 years, he has worked in both established and startup medical device and life science companies, where he has guided companies from IPO through to successful exit strategies. Travis’ knowledge and expertise lies in establishing strategic goals, vertically integrating operations, implementing lean manufacturing, identifying untapped revenue opportunities, restructuring teams for high performance and rapid growth, and commercializing new products.
“I am very honored and excited to join the Adaptiiv team. Adaptiiv’s transforming technology and leadership team deliver meaningful and significant clinical treatment solutions to radiation therapy providers and their patients on a global scale,” says Gay.
Travis is an exciting addition to Adaptiiv and we extend a warm welcome to him from the entire team.
– Peter Hickey, CEO
Adaptiiv Medical Technologies Inc.
Adaptiiv Medical Technologies Inc. is the definitive software platform to design 3D printed medical accessories for use in radiation oncology. Headquartered in Halifax, Nova Scotia, Canada, Adaptiiv is shaping the future of patient-specific healthcare through innovation and collaboration with industry leaders throughout the world. Adaptiiv has FDA 510(k) clearance and has received a CE Mark. The company’s solution is currently used in a clinical setting by clients in 13 countries.